Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on...
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the...
In 2024, the American Association for Cancer Research (AACR) released the 14th edition of the annual AACR Cancer Progress...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
By Vivek Subbiah, MD, Sarah Cannon Research Institute It is both the best of times and a challenging time...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
When the chemotherapy drug 5-fluorouracil (5-FU) was approved in 1962, there was limited understanding of how it is metabolized...
Studies presented at the 2024 SABCS examined ways to predict responses to treatments for HR-positive, HER2-negative breast cancer.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management...
What did we learn about cancer in 2024? How did research advance our understanding of cancer? What new approvals...
The Black TNBC Sanctuary is a resource that provides key information and resources specifically for Black patients with TNBC.